Consolidated Statement of Operations - USD ($)	12 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Details
Revenues	$ 6,157,185	$ 11,528,813
Cost of expenses
Cost of revenues	2,277,356	6,187,442
Research and development expenses	206,884	338,001
Selling, general, and administrative expenses	2,520,133	6,466,682
Impairment charges	0	9,874,281
Operating Expenses	5,004,373	22,866,406
Income/(Loss) from operations	1,152,812	(11,337,593)
Interest expense - related party	1,056,913	906,567
Other loss	0	22,761
Income/(Loss) before income taxes	95,899	(12,266,921)
Provision for income taxes	2,701	36,918
Net Income/(Loss)	$ 93,198	$ (12,303,839)
Net income/(loss) per common share - basic	$ 0.01	$ (1.60)
Net income/(loss) per common share - diluted	$ 0.01	$ (1.60)
Weighted average number of common shares outstanding - basic	7,712,091	7,710,561
Weighted average number of common shares outstanding - diluted	7,751,988	7,710,561